纵横研报
Ticker Detail

603998.SHG

¥10.17+2.94% 方盛制药 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Hunan Fangsheng Pharm Co Ltd
医疗健康 · 专科与仿制药

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, neurological drugs, gynecological drugs, and anti-infective drugs. Its products include Xuesaitong dispersible tablets; Xuesaitong tablets; Garcinia Cambogia bone strengthening tablets; Lysine Vitamin B12 granules; Cephalosporin tablets, Jinying capsules; Pudilan anti-inflammatory tablets; Tenghuang Jian Gu tablets; Xiaoer Jingxing Zhike granules; Yizhemaibu tablets; Xuanqi Jian tablets; Xuanqi Jian Gu tablets, Qiangli Pipa Gao, strong loquat syrup, and others. Hunan Fangsheng Pharmaceutical Co., Ltd. was founded in 2002 and is based in Changsha, China.

MARKET 市值 4.08B CNY PE 13.3x 52W ¥8.64 – ¥13.5 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY 10.7% ROE 16.8% 营业利润率 22.7% 净利润率 17.1%
ANALYST 股息率 3.27%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制